CRIM1
Basic information
Region (hg38): 2:36355778-36551135
Previous symbols: [ "S52" ]
Links
Phenotypes
GenCC
Source:
- colobomatous macrophthalmia-microcornea syndrome (Supportive), mode of inheritance: AD
- colobomatous macrophthalmia-microcornea syndrome (Limited), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CRIM1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 15 | |||||
missense | 56 | 68 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 1 | 3 | |||
non coding | 1 | |||||
Total | 0 | 0 | 57 | 14 | 14 |
Variants in CRIM1
This is a list of pathogenic ClinVar variants found in the CRIM1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-36356299-T-G | not specified | Uncertain significance (Aug 17, 2021) | ||
2-36356318-G-T | CRIM1-related disorder | Benign (Jun 26, 2019) | ||
2-36356329-T-C | not specified | Uncertain significance (Sep 12, 2023) | ||
2-36356357-G-T | not specified | Uncertain significance (Feb 28, 2023) | ||
2-36356368-C-A | CRIM1-related disorder | Benign (Jul 01, 2019) | ||
2-36356433-G-A | Likely benign (Mar 02, 2018) | |||
2-36356582-A-G | not specified | Uncertain significance (Jul 26, 2022) | ||
2-36356596-A-C | not specified | Uncertain significance (Apr 12, 2024) | ||
2-36356616-T-C | CRIM1-related disorder | Benign (Dec 31, 2019) | ||
2-36356620-G-C | not specified | Uncertain significance (Sep 22, 2023) | ||
2-36356628-G-A | CRIM1-related disorder | Benign (Jul 13, 2018) | ||
2-36396688-A-G | not specified | Uncertain significance (Sep 20, 2023) | ||
2-36396719-G-A | not specified | Uncertain significance (Dec 02, 2022) | ||
2-36441250-C-T | CRIM1-related disorder | Likely benign (Nov 06, 2019) | ||
2-36441284-C-T | not specified | Uncertain significance (May 31, 2023) | ||
2-36441350-C-G | not specified | Uncertain significance (Apr 16, 2024) | ||
2-36441366-C-G | not specified | Uncertain significance (Aug 08, 2023) | ||
2-36441430-C-T | Likely benign (May 15, 2018) | |||
2-36441451-A-G | CRIM1-related disorder | Benign (Dec 31, 2019) | ||
2-36441465-C-T | not specified | Uncertain significance (May 04, 2022) | ||
2-36441495-A-C | not specified | Uncertain significance (Aug 21, 2023) | ||
2-36442606-C-T | CRIM1-related disorder | Likely benign (Feb 26, 2020) | ||
2-36442632-A-G | not specified | Uncertain significance (Jun 04, 2024) | ||
2-36442638-G-A | not specified | Uncertain significance (Feb 08, 2023) | ||
2-36442671-C-G | not specified | Uncertain significance (Jan 23, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CRIM1 | protein_coding | protein_coding | ENST00000280527 | 17 | 195210 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000286 | 125736 | 0 | 12 | 125748 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.194 | 587 | 600 | 0.978 | 0.0000349 | 6794 |
Missense in Polyphen | 346 | 383.26 | 0.90278 | 4341 | ||
Synonymous | -2.84 | 291 | 235 | 1.24 | 0.0000147 | 1970 |
Loss of Function | 5.75 | 6 | 49.8 | 0.120 | 0.00000237 | 612 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000149 | 0.000149 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000707 | 0.0000527 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000341 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in CNS development by interacting with growth factors implicated in motor neuron differentiation and survival. May play a role in capillary formation and maintenance during angiogenesis. Modulates BMP activity by affecting its processing and delivery to the cell surface. {ECO:0000269|PubMed:12464430, ECO:0000269|PubMed:12805376}.;
- Pathway
- EGFR1
(Consensus)
Intolerance Scores
- loftool
- 0.249
- rvis_EVS
- -1.1
- rvis_percentile_EVS
- 6.93
Haploinsufficiency Scores
- pHI
- 0.264
- hipred
- Y
- hipred_score
- 0.605
- ghis
- 0.545
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.964
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Crim1
- Phenotype
- limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; vision/eye phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; embryo phenotype; liver/biliary system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); endocrine/exocrine gland phenotype; muscle phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- regulation of cell growth;nervous system development;negative regulation of endopeptidase activity;insulin-like growth factor receptor signaling pathway
- Cellular component
- extracellular region;plasma membrane;integral component of membrane
- Molecular function
- serine-type endopeptidase inhibitor activity;insulin-like growth factor-activated receptor activity;insulin-like growth factor binding;PDZ domain binding